TickerFacts.

C21 Investments Inc. (CWLXF): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$4.06M
Year ended 2026-03-31
$11.57M2021-01-31: $11.51M2022-01-31: $11.57M2023-01-31: $5.80M2024-01-31: $2.88M2025-03-31: $2.99M2026-03-31: $4.06M$4.06M
2021-01-31 EBITDA (USD) 2026-03-31
Period endedEBITDAChange YoYSource filing
2026-03-31$4.06M+35.8%2026-06-12, From 2025-04-01
2025-03-31$2.99Mn/a2026-06-12, From 2024-04-01
No annual figure between 2024-01-31 and 2025-03-31.
2024-01-31$2.88M-50.3%2025-06-23, From 2023-02-01
2023-01-31$5.80M-49.9%2024-08-08, From 2022-02-01
2022-01-31$11.57M+0.5%2023-07-28, From 2021-02-01
2021-01-31$11.51Mn/a2023-07-28, From 2020-02-01

EBITDA at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
C21 Investments Inc. (CWLXF)2026-03-31$4.06M+35.8%
Leef Brands Inc. (LEEEF)2025-12-31-$6.33Mn/m
Synergy CHC Corp. (SNYRQ)2025-12-31-$8.33Mn/m
Cyanotech Corp (CYAN)2025-03-31-$1.03Mn/m
Charlie's Holdings, Inc. (CHUC)2025-12-31-$2.13Mn/m
Bon Natural Life Ltd (BON)2025-09-30-$535.6Kn/m
Fitlife Brands, Inc. (FTLF)2025-12-31$10.48M-20.8%
Mannatech Inc (MTEX)2025-12-31$666.0K-77.5%
Natural Alternatives International Inc (NAII)2025-06-30-$4.10Mn/m

Compare CWLXF, LEEEF, SNYRQ, CYAN side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗